Cargando…
Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
BACKGROUND: Complete response after neoadjuvant chemotherapy (rNACT) elevates the surgical outcomes of patients with breast cancer, however, non-rNACT have a higher risk of death and recurrence. AIM: To establish novel machine learning (ML)-based predictive models for predicting probability of rNACT...
Autores principales: | Ke, Zi-Rui, Chen, Wei, Li, Man-Xiu, Wu, Shun, Jin, Li-Ting, Wang, Tie-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048567/ https://www.ncbi.nlm.nih.gov/pubmed/35611192 http://dx.doi.org/10.12998/wjcc.v10.i11.3389 |
Ejemplares similares
-
Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes
por: Liu, Yi, et al.
Publicado: (2018) -
Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy
por: Cui, Hao, et al.
Publicado: (2022) -
Preoperative neoadjuvant chemotherapy in patients with breast cancer evaluated using strain ultrasonic elastography
por: Pan, Hong-Yu, et al.
Publicado: (2022) -
Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022) -
Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)